FOR PEOPLE WHO HAVE RECEIVED AT LEAST 1 PRIOR THERAPY

Extend the possibilities
in multiple myeloma treatment

NINLARO® (ixazomib) is the first and only oral medication of its kind, a proteasome inhibitor, that you can take at home. A study showed that adding NINLARO to REVLIMID® (lenalidomide) and dexamethasone improved median progression-free survival (PFS) by nearly 6 months (20.6 months with the NINLARO regimen and 14.7 months with the placebo regimen). 

NINLARO® (ixazomib) - Multiple Myeloma Treatment
NINLARO® (ixazomib) - Multiple Myeloma Treatment